Verzenio® (abemaciclib)
for Breast Cancer

Verzenio (abemaciclib) is a targeted therapy for HR-positive, HER2-negative breast cancer, used for both early-stage and metastatic disease. It is often combined with other treatments but can also be used alone. As a CDK4/6 inhibitor, Verzenio blocks proteins that help cancer cells grow and divide, slowing tumor progression and promoting shrinkage.

Heart
Other top medicines used to treat Breast Cancer